Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 8.05306217 |
2 | muscle filament sliding (GO:0030049) | 7.69337188 |
3 | actin-myosin filament sliding (GO:0033275) | 7.69337188 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.32556064 |
5 | cardiac myofibril assembly (GO:0055003) | 7.28456900 |
6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.27917674 |
7 | myofibril assembly (GO:0030239) | 7.02036774 |
8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.79302064 |
9 | regulation of skeletal muscle contraction (GO:0014819) | 6.62594620 |
10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.53604929 |
11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.45603031 |
12 | plasma membrane repair (GO:0001778) | 6.41242661 |
13 | actin-mediated cell contraction (GO:0070252) | 6.38076869 |
14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.28168976 |
15 | cardiac muscle contraction (GO:0060048) | 6.08365749 |
16 | response to muscle activity (GO:0014850) | 5.93933864 |
17 | regulation of relaxation of muscle (GO:1901077) | 5.75766143 |
18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.75755466 |
19 | regulation of cell communication by electrical coupling (GO:0010649) | 5.73591254 |
20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.67449595 |
21 | tricarboxylic acid cycle (GO:0006099) | 5.60304165 |
22 | striated muscle contraction (GO:0006941) | 5.46622367 |
23 | regulation of actin filament-based movement (GO:1903115) | 5.46301134 |
24 | cardiac muscle cell development (GO:0055013) | 5.34031327 |
25 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.29243815 |
26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.25299850 |
27 | actomyosin structure organization (GO:0031032) | 5.24334410 |
28 | skeletal muscle fiber development (GO:0048741) | 5.06021528 |
29 | cardiac cell development (GO:0055006) | 4.99453150 |
30 | carnitine shuttle (GO:0006853) | 4.93181533 |
31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.92426287 |
32 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.88472508 |
33 | cardiac muscle hypertrophy (GO:0003300) | 4.80151410 |
34 | actin filament-based movement (GO:0030048) | 4.79652966 |
35 | regulation of membrane repolarization (GO:0060306) | 4.72980644 |
36 | skeletal muscle contraction (GO:0003009) | 4.72339856 |
37 | myotube cell development (GO:0014904) | 4.71669934 |
38 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.71569443 |
39 | regulation of striated muscle contraction (GO:0006942) | 4.66610841 |
40 | regulation of sarcomere organization (GO:0060297) | 4.66508139 |
41 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.65314755 |
42 | striated muscle hypertrophy (GO:0014897) | 4.64697572 |
43 | adult heart development (GO:0007512) | 4.60434971 |
44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.60038667 |
45 | regulation of cofactor metabolic process (GO:0051193) | 4.52752389 |
46 | regulation of coenzyme metabolic process (GO:0051196) | 4.52752389 |
47 | cell communication involved in cardiac conduction (GO:0086065) | 4.36282619 |
48 | muscle tissue morphogenesis (GO:0060415) | 4.32611762 |
49 | heart contraction (GO:0060047) | 4.30727562 |
50 | heart process (GO:0003015) | 4.30727562 |
51 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.25674194 |
52 | glucan catabolic process (GO:0009251) | 4.25463398 |
53 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.19166144 |
54 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.15561191 |
55 | fatty acid transmembrane transport (GO:1902001) | 4.14772435 |
56 | glucan biosynthetic process (GO:0009250) | 4.11564388 |
57 | glycogen biosynthetic process (GO:0005978) | 4.11564388 |
58 | muscle hypertrophy (GO:0014896) | 4.06521515 |
59 | cell communication by electrical coupling (GO:0010644) | 4.00910944 |
60 | heart trabecula formation (GO:0060347) | 3.99845939 |
61 | cellular polysaccharide catabolic process (GO:0044247) | 3.97746872 |
62 | skeletal muscle tissue development (GO:0007519) | 3.95617657 |
63 | regulation of the force of heart contraction (GO:0002026) | 3.94881085 |
64 | muscle contraction (GO:0006936) | 3.92865622 |
65 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.92403945 |
66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.92181289 |
67 | muscle cell cellular homeostasis (GO:0046716) | 3.91957317 |
68 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.89983140 |
69 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.89983140 |
70 | creatine metabolic process (GO:0006600) | 3.87135102 |
71 | skeletal muscle adaptation (GO:0043501) | 3.83994668 |
72 | cardiac muscle cell action potential (GO:0086001) | 3.77822818 |
73 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.76540153 |
74 | regulation of cardiac muscle contraction (GO:0055117) | 3.76059383 |
75 | negative regulation of potassium ion transport (GO:0043267) | 3.75337575 |
76 | response to inactivity (GO:0014854) | 3.73059409 |
77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.72251660 |
78 | respiratory electron transport chain (GO:0022904) | 3.66457808 |
79 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.65051397 |
80 | muscle cell fate commitment (GO:0042693) | 3.64261882 |
81 | positive regulation of cation channel activity (GO:2001259) | 3.64212384 |
82 | regulation of heart rate (GO:0002027) | 3.63230467 |
83 | muscle system process (GO:0003012) | 3.61865294 |
84 | negative regulation of protein localization to cell surface (GO:2000009) | 3.61836470 |
85 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.61255537 |
86 | ATP synthesis coupled proton transport (GO:0015986) | 3.61255537 |
87 | regulation of sulfur metabolic process (GO:0042762) | 3.60605090 |
88 | striated muscle cell development (GO:0055002) | 3.57658769 |
89 | carnitine transmembrane transport (GO:1902603) | 3.57385842 |
90 | electron transport chain (GO:0022900) | 3.55289715 |
91 | polysaccharide catabolic process (GO:0000272) | 3.53524125 |
92 | NADH metabolic process (GO:0006734) | 3.49209810 |
93 | cardiac muscle adaptation (GO:0014887) | 3.49135115 |
94 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.49135115 |
95 | muscle hypertrophy in response to stress (GO:0003299) | 3.49135115 |
96 | striated muscle adaptation (GO:0014888) | 3.48358984 |
97 | skeletal muscle tissue regeneration (GO:0043403) | 3.44933711 |
98 | detection of calcium ion (GO:0005513) | 3.44128527 |
99 | muscle structure development (GO:0061061) | 3.43876314 |
100 | cardiac conduction (GO:0061337) | 3.42005392 |
101 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.42000446 |
102 | relaxation of cardiac muscle (GO:0055119) | 3.41701015 |
103 | muscle organ development (GO:0007517) | 3.41508345 |
104 | IMP metabolic process (GO:0046040) | 3.40518308 |
105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.38549993 |
106 | myotube differentiation (GO:0014902) | 3.37296479 |
107 | regulation of heart contraction (GO:0008016) | 3.34277472 |
108 | glycogen metabolic process (GO:0005977) | 3.33999825 |
109 | glycogen catabolic process (GO:0005980) | 3.32436633 |
110 | muscle cell development (GO:0055001) | 3.31083699 |
111 | muscle adaptation (GO:0043500) | 3.29733087 |
112 | muscle fiber development (GO:0048747) | 3.28659292 |
113 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.27776547 |
114 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.27705316 |
115 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.26537322 |
116 | regulation of ATP catabolic process (GO:1903289) | 3.26423779 |
117 | regulation of ATPase activity (GO:0043462) | 3.26423779 |
118 | cellular glucan metabolic process (GO:0006073) | 3.24377457 |
119 | glucan metabolic process (GO:0044042) | 3.24377457 |
120 | oxidative phosphorylation (GO:0006119) | 3.24028294 |
121 | amino-acid betaine transport (GO:0015838) | 3.21906468 |
122 | carnitine transport (GO:0015879) | 3.21906468 |
123 | regulation of muscle contraction (GO:0006937) | 3.20631074 |
124 | striated muscle atrophy (GO:0014891) | 3.16343739 |
125 | response to caffeine (GO:0031000) | 3.08164494 |
126 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.07874313 |
127 | gluconeogenesis (GO:0006094) | 3.05768229 |
128 | myoblast fusion (GO:0007520) | 3.00491742 |
129 | regulation of muscle system process (GO:0090257) | 2.99644717 |
130 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.98429582 |
131 | muscle atrophy (GO:0014889) | 2.97716619 |
132 | regulation of myoblast differentiation (GO:0045661) | 2.97292800 |
133 | positive regulation of myotube differentiation (GO:0010831) | 2.96632046 |
134 | response to activity (GO:0014823) | 2.96164437 |
135 | mitochondrial genome maintenance (GO:0000002) | 2.95055884 |
136 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.92156247 |
137 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.92156247 |
138 | striated muscle tissue development (GO:0014706) | 2.91940435 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.68656931 |
2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.85682868 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.82402797 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75053170 |
5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.19215168 |
6 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.84236968 |
7 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.84236968 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.77608895 |
9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46805114 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32238743 |
11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.30604159 |
12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.28237296 |
13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.28043512 |
14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.08357012 |
15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.98779294 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96378128 |
17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.95278378 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93584949 |
19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91564334 |
20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87406389 |
21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87406389 |
22 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.83304966 |
23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.81236053 |
24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.79506991 |
25 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.74156635 |
26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73021721 |
27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70984131 |
28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70299690 |
29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.69486265 |
30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60775280 |
31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.60374521 |
32 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.56493256 |
33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55217239 |
34 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.53868096 |
35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.52945980 |
36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47186676 |
37 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.46697729 |
38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45549581 |
39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.45009855 |
40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43925191 |
41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43556071 |
42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42891003 |
43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38750151 |
44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38190854 |
45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37808487 |
46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32254040 |
47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.32192824 |
48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30579553 |
49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30217818 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29458303 |
51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29249498 |
52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25948820 |
53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23135327 |
54 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.22294703 |
55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20315894 |
56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20177878 |
57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20118904 |
58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19010360 |
59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16306634 |
60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16220048 |
61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15865976 |
62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15616372 |
63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15314361 |
64 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.14856124 |
65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14813954 |
66 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14507779 |
67 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14300236 |
68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13793169 |
69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11763924 |
70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11641448 |
71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10712931 |
72 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09422668 |
73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08425194 |
74 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.08251586 |
75 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07027365 |
76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06656505 |
77 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06220491 |
78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04618245 |
79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04558396 |
80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04368961 |
81 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04326145 |
82 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03396985 |
83 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02617974 |
84 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02588860 |
85 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.02426929 |
86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01521146 |
87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01029922 |
88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00811903 |
89 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00572275 |
90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99689635 |
91 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98443288 |
92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97949184 |
93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97886175 |
94 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97700946 |
95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97230559 |
96 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95222298 |
97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95180852 |
98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95033443 |
99 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95018205 |
100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94530476 |
101 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94232650 |
102 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.93516448 |
103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93482392 |
104 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92934750 |
105 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92495889 |
106 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92471809 |
107 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92091102 |
108 | * AR_19668381_ChIP-Seq_PC3_Human | 0.91968859 |
109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91011876 |
110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90268470 |
111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90172016 |
112 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.89011618 |
113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88667843 |
114 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.88497553 |
115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87413759 |
116 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87382771 |
117 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87271381 |
118 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86946683 |
119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86789624 |
120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.86621527 |
121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86215351 |
122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86029032 |
123 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.85973339 |
124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84963272 |
125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84785863 |
126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84785863 |
127 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.84256421 |
128 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84253037 |
129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83619840 |
130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83590718 |
131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.82733725 |
132 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.81672905 |
133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81545848 |
134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81539019 |
135 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81091932 |
136 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81087057 |
137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81028071 |
138 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81004865 |
139 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80592089 |
140 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80478921 |
141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80026818 |
142 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80009639 |
143 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79596467 |
144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79407025 |
145 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79222178 |
146 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.78557447 |
147 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.77840129 |
148 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77519388 |
149 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76592042 |
150 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76397516 |
151 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76367915 |
152 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75780306 |
153 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.75734652 |
154 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75286091 |
155 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74295632 |
156 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74040650 |
157 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73574525 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.15903952 |
2 | MP0003646_muscle_fatigue | 5.79880717 |
3 | MP0000751_myopathy | 5.44375883 |
4 | MP0004084_abnormal_cardiac_muscle | 4.93999554 |
5 | MP0000749_muscle_degeneration | 4.49098248 |
6 | MP0004036_abnormal_muscle_relaxation | 4.32656219 |
7 | MP0004215_abnormal_myocardial_fiber | 4.22402119 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.86727714 |
9 | MP0005330_cardiomyopathy | 3.43474466 |
10 | MP0004087_abnormal_muscle_fiber | 3.15830673 |
11 | MP0002106_abnormal_muscle_physiology | 2.91897779 |
12 | MP0005620_abnormal_muscle_contractility | 2.90231084 |
13 | MP0002972_abnormal_cardiac_muscle | 2.82993457 |
14 | MP0000750_abnormal_muscle_regeneration | 2.72067601 |
15 | MP0004130_abnormal_muscle_cell | 2.66385672 |
16 | MP0000747_muscle_weakness | 2.65542632 |
17 | MP0003137_abnormal_impulse_conducting | 2.61944091 |
18 | MP0002269_muscular_atrophy | 2.56271143 |
19 | MP0008775_abnormal_heart_ventricle | 2.48211236 |
20 | MP0004484_altered_response_of | 2.44032086 |
21 | MP0000759_abnormal_skeletal_muscle | 2.41171107 |
22 | MP0005369_muscle_phenotype | 2.41018816 |
23 | MP0010630_abnormal_cardiac_muscle | 2.22215919 |
24 | MP0005385_cardiovascular_system_phenoty | 2.20005281 |
25 | MP0001544_abnormal_cardiovascular_syste | 2.20005281 |
26 | MP0004233_abnormal_muscle_weight | 2.10476572 |
27 | MP0006138_congestive_heart_failure | 1.94281159 |
28 | MP0004085_abnormal_heartbeat | 1.94049569 |
29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.76796235 |
30 | MP0004510_myositis | 1.70849042 |
31 | MP0001661_extended_life_span | 1.68821777 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.65473381 |
33 | MP0003828_pulmonary_edema | 1.62942047 |
34 | MP0002332_abnormal_exercise_endurance | 1.61132553 |
35 | MP0002127_abnormal_cardiovascular_syste | 1.50974419 |
36 | MP0003950_abnormal_plasma_membrane | 1.41299939 |
37 | MP0005666_abnormal_adipose_tissue | 1.20047982 |
38 | MP0002108_abnormal_muscle_morphology | 1.16274805 |
39 | MP0002234_abnormal_pharynx_morphology | 1.08619445 |
40 | MP0006035_abnormal_mitochondrial_morpho | 1.08019530 |
41 | MP0004270_analgesia | 1.03312912 |
42 | MP0010030_abnormal_orbit_morphology | 1.00646464 |
43 | MP0004859_abnormal_synaptic_plasticity | 0.98578412 |
44 | MP0004185_abnormal_adipocyte_glucose | 0.97171594 |
45 | MP0000266_abnormal_heart_morphology | 0.96100189 |
46 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92021823 |
47 | MP0000733_abnormal_muscle_development | 0.86789877 |
48 | MP0005670_abnormal_white_adipose | 0.83738713 |
49 | MP0005375_adipose_tissue_phenotype | 0.83107700 |
50 | MP0005165_increased_susceptibility_to | 0.82567706 |
51 | MP0000343_altered_response_to | 0.81509545 |
52 | MP0000013_abnormal_adipose_tissue | 0.78196106 |
53 | MP0005623_abnormal_meninges_morphology | 0.78183992 |
54 | MP0009672_abnormal_birth_weight | 0.78065705 |
55 | MP0005266_abnormal_metabolism | 0.77639387 |
56 | MP0003941_abnormal_skin_development | 0.75761566 |
57 | MP0002909_abnormal_adrenal_gland | 0.73514949 |
58 | MP0000230_abnormal_systemic_arterial | 0.72547086 |
59 | MP0004134_abnormal_chest_morphology | 0.68517796 |
60 | MP0002822_catalepsy | 0.65912701 |
61 | MP0010368_abnormal_lymphatic_system | 0.65810276 |
62 | MP0004043_abnormal_pH_regulation | 0.64265010 |
63 | MP0005386_behavior/neurological_phenoty | 0.62674346 |
64 | MP0004924_abnormal_behavior | 0.62674346 |
65 | MP0000372_irregular_coat_pigmentation | 0.62506629 |
66 | MP0002735_abnormal_chemical_nociception | 0.61398482 |
67 | MP0003635_abnormal_synaptic_transmissio | 0.60836507 |
68 | MP0002971_abnormal_brown_adipose | 0.60244832 |
69 | MP0003279_aneurysm | 0.59597787 |
70 | MP0000762_abnormal_tongue_morphology | 0.58981543 |
71 | MP0009250_abnormal_appendicular_skeleto | 0.57265983 |
72 | MP0002128_abnormal_blood_circulation | 0.57108264 |
73 | MP0008569_lethality_at_weaning | 0.56502729 |
74 | MP0009046_muscle_twitch | 0.55387735 |
75 | MP0002114_abnormal_axial_skeleton | 0.54396569 |
76 | MP0003880_abnormal_central_pattern | 0.53145956 |
77 | MP0009780_abnormal_chondrocyte_physiolo | 0.52980432 |
78 | MP0009384_cardiac_valve_regurgitation | 0.52751144 |
79 | MP0000003_abnormal_adipose_tissue | 0.51736169 |
80 | MP0005187_abnormal_penis_morphology | 0.49226816 |
81 | MP0009745_abnormal_behavioral_response | 0.49225910 |
82 | MP0002272_abnormal_nervous_system | 0.49175918 |
83 | MP0008961_abnormal_basal_metabolism | 0.48716756 |
84 | MP0004147_increased_porphyrin_level | 0.48043146 |
85 | MP0002734_abnormal_mechanical_nocicepti | 0.47684349 |
86 | MP0004858_abnormal_nervous_system | 0.45351763 |
87 | MP0001440_abnormal_grooming_behavior | 0.44814405 |
88 | MP0002078_abnormal_glucose_homeostasis | 0.44665374 |
89 | MP0004197_abnormal_fetal_growth/weight/ | 0.44610656 |
90 | MP0009697_abnormal_copulation | 0.44570121 |
91 | MP0001299_abnormal_eye_distance/ | 0.43005371 |
92 | MP0002067_abnormal_sensory_capabilities | 0.42854790 |
93 | MP0002896_abnormal_bone_mineralization | 0.42820942 |
94 | MP0002064_seizures | 0.42679590 |
95 | MP0003984_embryonic_growth_retardation | 0.40708293 |
96 | MP0005535_abnormal_body_temperature | 0.39855359 |
97 | MP0002088_abnormal_embryonic_growth/wei | 0.39133345 |
98 | MP0003705_abnormal_hypodermis_morpholog | 0.38448501 |
99 | MP0006276_abnormal_autonomic_nervous | 0.38311186 |
100 | MP0002063_abnormal_learning/memory/cond | 0.38175301 |
101 | MP0003385_abnormal_body_wall | 0.37471057 |
102 | MP0001346_abnormal_lacrimal_gland | 0.37416850 |
103 | MP0003123_paternal_imprinting | 0.37024032 |
104 | MP0001879_abnormal_lymphatic_vessel | 0.36983030 |
105 | MP0005275_abnormal_skin_tensile | 0.35714020 |
106 | MP0001529_abnormal_vocalization | 0.35223071 |
107 | MP0000534_abnormal_ureter_morphology | 0.34927761 |
108 | MP0003948_abnormal_gas_homeostasis | 0.34748426 |
109 | MP0001968_abnormal_touch/_nociception | 0.33826083 |
110 | MP0003566_abnormal_cell_adhesion | 0.33217417 |
111 | MP0009703_decreased_birth_body | 0.33200974 |
112 | MP0005452_abnormal_adipose_tissue | 0.33115362 |
113 | MP0002066_abnormal_motor_capabilities/c | 0.33008934 |
114 | MP0004142_abnormal_muscle_tone | 0.32069718 |
115 | MP0004272_abnormal_basement_membrane | 0.31640595 |
116 | MP0001970_abnormal_pain_threshold | 0.31354254 |
117 | MP0005380_embryogenesis_phenotype | 0.31323863 |
118 | MP0001672_abnormal_embryogenesis/_devel | 0.31323863 |
119 | MP0003045_fibrosis | 0.31011139 |
120 | MP0002925_abnormal_cardiovascular_devel | 0.30975835 |
121 | MP0001730_embryonic_growth_arrest | 0.30613799 |
122 | MP0000767_abnormal_smooth_muscle | 0.28510362 |
123 | MP0005451_abnormal_body_composition | 0.27824013 |
124 | MP0003329_amyloid_beta_deposits | 0.26827711 |
125 | MP0001984_abnormal_olfaction | 0.26713411 |
126 | MP0001943_abnormal_respiration | 0.25479645 |
127 | MP0002638_abnormal_pupillary_reflex | 0.24338501 |
128 | MP0003755_abnormal_palate_morphology | 0.24131351 |
129 | MP0005334_abnormal_fat_pad | 0.23887243 |
130 | MP0003942_abnormal_urinary_system | 0.22850593 |
131 | MP0002081_perinatal_lethality | 0.22650719 |
132 | MP0003937_abnormal_limbs/digits/tail_de | 0.22520932 |
133 | MP0005376_homeostasis/metabolism_phenot | 0.22276671 |
134 | MP0001697_abnormal_embryo_size | 0.21160605 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.11256784 |
2 | Exercise-induced myalgia (HP:0003738) | 7.10667455 |
3 | Calf muscle hypertrophy (HP:0008981) | 6.73425649 |
4 | Exercise-induced muscle cramps (HP:0003710) | 6.67422515 |
5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.60039995 |
6 | Muscle fiber splitting (HP:0003555) | 5.76757967 |
7 | Ventricular tachycardia (HP:0004756) | 5.58086788 |
8 | Abnormality of the calf musculature (HP:0001430) | 5.38002812 |
9 | Hyporeflexia of lower limbs (HP:0002600) | 5.24703857 |
10 | Muscle fiber inclusion bodies (HP:0100299) | 5.10811681 |
11 | Myoglobinuria (HP:0002913) | 5.05578572 |
12 | Atrial fibrillation (HP:0005110) | 4.97309429 |
13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.94844141 |
14 | Primary atrial arrhythmia (HP:0001692) | 4.67636250 |
15 | Subaortic stenosis (HP:0001682) | 4.67518270 |
16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.67518270 |
17 | EMG: myopathic abnormalities (HP:0003458) | 4.61297142 |
18 | Supraventricular tachycardia (HP:0004755) | 4.50173871 |
19 | Supraventricular arrhythmia (HP:0005115) | 4.40189587 |
20 | Difficulty running (HP:0009046) | 4.33434007 |
21 | Lipoatrophy (HP:0100578) | 4.30199195 |
22 | Nemaline bodies (HP:0003798) | 4.30123429 |
23 | Type 1 muscle fiber predominance (HP:0003803) | 4.25403060 |
24 | Syncope (HP:0001279) | 4.07193524 |
25 | Myotonia (HP:0002486) | 4.03973886 |
26 | Increased connective tissue (HP:0009025) | 4.02599547 |
27 | Bundle branch block (HP:0011710) | 3.94321075 |
28 | Right ventricular cardiomyopathy (HP:0011663) | 3.92801201 |
29 | Rhabdomyolysis (HP:0003201) | 3.84510310 |
30 | Prolonged QT interval (HP:0001657) | 3.77023020 |
31 | Asymmetric septal hypertrophy (HP:0001670) | 3.72410823 |
32 | Calcaneovalgus deformity (HP:0001848) | 3.68436521 |
33 | Dilated cardiomyopathy (HP:0001644) | 3.61658940 |
34 | Palpitations (HP:0001962) | 3.56851860 |
35 | Ventricular arrhythmia (HP:0004308) | 3.49207180 |
36 | Muscle stiffness (HP:0003552) | 3.37333710 |
37 | Deformed tarsal bones (HP:0008119) | 3.21246702 |
38 | Distal arthrogryposis (HP:0005684) | 3.20555131 |
39 | Heart block (HP:0012722) | 3.19270321 |
40 | Ventricular fibrillation (HP:0001663) | 3.19062836 |
41 | Difficulty climbing stairs (HP:0003551) | 3.17237907 |
42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.04607841 |
43 | Abnormal atrioventricular conduction (HP:0005150) | 3.00603725 |
44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.96677898 |
45 | Neck muscle weakness (HP:0000467) | 2.92273580 |
46 | Atrioventricular block (HP:0001678) | 2.90205364 |
47 | Areflexia of lower limbs (HP:0002522) | 2.84846790 |
48 | Malignant hyperthermia (HP:0002047) | 2.83367575 |
49 | Abnormal EKG (HP:0003115) | 2.82870271 |
50 | Rimmed vacuoles (HP:0003805) | 2.82129580 |
51 | Myopathic facies (HP:0002058) | 2.81033604 |
52 | Round ear (HP:0100830) | 2.75500882 |
53 | Left ventricular hypertrophy (HP:0001712) | 2.71865824 |
54 | Abnormal finger flexion creases (HP:0006143) | 2.69860167 |
55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68762255 |
56 | Acute necrotizing encephalopathy (HP:0006965) | 2.67135242 |
57 | Distal lower limb muscle weakness (HP:0009053) | 2.63808218 |
58 | Slender build (HP:0001533) | 2.41040147 |
59 | Limb-girdle muscle atrophy (HP:0003797) | 2.38921939 |
60 | Bulbar palsy (HP:0001283) | 2.38887083 |
61 | Spinal rigidity (HP:0003306) | 2.36991800 |
62 | EMG: neuropathic changes (HP:0003445) | 2.33704143 |
63 | Hepatic necrosis (HP:0002605) | 2.32213201 |
64 | Progressive macrocephaly (HP:0004481) | 2.26274480 |
65 | Muscular dystrophy (HP:0003560) | 2.26166441 |
66 | Pheochromocytoma (HP:0002666) | 2.23252135 |
67 | Hyperkalemia (HP:0002153) | 2.22121141 |
68 | Abnormality of the calcaneus (HP:0008364) | 2.21800158 |
69 | Acute encephalopathy (HP:0006846) | 2.20294413 |
70 | Abnormality of the foot musculature (HP:0001436) | 2.20173974 |
71 | Hepatocellular necrosis (HP:0001404) | 2.18296626 |
72 | Hypoplastic ischia (HP:0003175) | 2.16276397 |
73 | Hip contracture (HP:0003273) | 2.15853649 |
74 | Foot dorsiflexor weakness (HP:0009027) | 2.15367479 |
75 | Fetal akinesia sequence (HP:0001989) | 2.14988614 |
76 | Palmoplantar keratoderma (HP:0000982) | 2.14403298 |
77 | Weak cry (HP:0001612) | 2.13947045 |
78 | Distal lower limb amyotrophy (HP:0008944) | 2.13930688 |
79 | Mitochondrial inheritance (HP:0001427) | 2.13045770 |
80 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.12592208 |
81 | Gowers sign (HP:0003391) | 2.11688275 |
82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09637150 |
83 | Ulnar deviation of the wrist (HP:0003049) | 2.06610413 |
84 | Ketoacidosis (HP:0001993) | 2.05897430 |
85 | Exercise intolerance (HP:0003546) | 2.05291337 |
86 | Scapular winging (HP:0003691) | 2.03969620 |
87 | Shoulder girdle muscle weakness (HP:0003547) | 2.03302347 |
88 | Frequent falls (HP:0002359) | 2.02791844 |
89 | Generalized muscle weakness (HP:0003324) | 2.00897541 |
90 | Neuroendocrine neoplasm (HP:0100634) | 1.99562577 |
91 | Increased CSF lactate (HP:0002490) | 1.99476322 |
92 | Waddling gait (HP:0002515) | 1.95495935 |
93 | Abnormality of the ischium (HP:0003174) | 1.95173876 |
94 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.94891820 |
95 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.94891820 |
96 | Increased muscle lipid content (HP:0009058) | 1.94806498 |
97 | Dysmetric saccades (HP:0000641) | 1.94555716 |
98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92357496 |
99 | Facial diplegia (HP:0001349) | 1.91900251 |
100 | Abnormality of the neuromuscular junction (HP:0003398) | 1.91596849 |
101 | Fatigable weakness (HP:0003473) | 1.91596849 |
102 | Proximal amyotrophy (HP:0007126) | 1.91386479 |
103 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91362624 |
104 | Abnormality of alanine metabolism (HP:0010916) | 1.91362624 |
105 | Hyperalaninemia (HP:0003348) | 1.91362624 |
106 | Conjunctival hamartoma (HP:0100780) | 1.90981808 |
107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.88296169 |
108 | Testicular atrophy (HP:0000029) | 1.87373298 |
109 | Ragged-red muscle fibers (HP:0003200) | 1.85759269 |
110 | Cerebral edema (HP:0002181) | 1.85446308 |
111 | Pelvic girdle muscle weakness (HP:0003749) | 1.85413991 |
112 | Central scotoma (HP:0000603) | 1.85225321 |
113 | Lower limb amyotrophy (HP:0007210) | 1.85122149 |
114 | Limb-girdle muscle weakness (HP:0003325) | 1.81443177 |
115 | Absent phalangeal crease (HP:0006109) | 1.80152613 |
116 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79634362 |
117 | Long clavicles (HP:0000890) | 1.77962145 |
118 | Progressive muscle weakness (HP:0003323) | 1.76099847 |
119 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.75301237 |
120 | Lactic acidosis (HP:0003128) | 1.74082386 |
121 | Hamartoma of the eye (HP:0010568) | 1.71671545 |
122 | Sudden cardiac death (HP:0001645) | 1.70986109 |
123 | Limited hip movement (HP:0008800) | 1.63241033 |
124 | Metatarsus adductus (HP:0001840) | 1.56684418 |
125 | Steppage gait (HP:0003376) | 1.55724600 |
126 | Popliteal pterygium (HP:0009756) | 1.49594930 |
127 | Oligomenorrhea (HP:0000876) | 1.44647906 |
128 | Ulnar deviation of finger (HP:0009465) | 1.42939303 |
129 | Nonprogressive disorder (HP:0003680) | 1.35896654 |
130 | Hypoalphalipoproteinemia (HP:0003233) | 1.29350430 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 6.24303240 |
2 | TTN | 5.56773316 |
3 | PHKG2 | 4.83669465 |
4 | PHKG1 | 4.83669465 |
5 | PDK3 | 3.19522077 |
6 | PDK4 | 3.19522077 |
7 | LMTK2 | 2.96767081 |
8 | DMPK | 2.79222847 |
9 | MYLK | 2.62897842 |
10 | NEK1 | 2.54238171 |
11 | PKN2 | 2.13994104 |
12 | PINK1 | 2.12629373 |
13 | PIK3CA | 2.07721435 |
14 | MUSK | 2.07148694 |
15 | EEF2K | 1.97499126 |
16 | PDK2 | 1.88323286 |
17 | TRIB3 | 1.86587346 |
18 | NME1 | 1.82394136 |
19 | STK24 | 1.70074549 |
20 | BCKDK | 1.57581056 |
21 | MAP3K7 | 1.41015638 |
22 | TIE1 | 1.28767244 |
23 | PAK3 | 1.25289140 |
24 | GRK7 | 1.23233191 |
25 | CAMK2D | 1.22470276 |
26 | MAPK12 | 1.20291954 |
27 | CCNB1 | 1.18407802 |
28 | MAP2K4 | 1.14170002 |
29 | MAP3K4 | 1.02152316 |
30 | PIK3CG | 1.00735212 |
31 | PRKD1 | 0.98149078 |
32 | MAP2K3 | 0.97348051 |
33 | ILK | 0.93355032 |
34 | ROCK1 | 0.88610525 |
35 | PRKAA1 | 0.87576236 |
36 | LATS2 | 0.85151500 |
37 | ZAK | 0.84724589 |
38 | CDC42BPA | 0.82555200 |
39 | STK38 | 0.81886723 |
40 | CAMK2A | 0.77518510 |
41 | ERBB3 | 0.77048654 |
42 | PRKAA2 | 0.76690601 |
43 | PAK6 | 0.76635096 |
44 | LATS1 | 0.75896734 |
45 | MAPKAPK3 | 0.75877793 |
46 | WNK4 | 0.75876677 |
47 | MAP3K10 | 0.75852813 |
48 | PKN1 | 0.75769835 |
49 | STK38L | 0.74316742 |
50 | RPS6KB2 | 0.72485237 |
51 | NTRK3 | 0.70316643 |
52 | WNK1 | 0.70180838 |
53 | MAP3K5 | 0.68608648 |
54 | RIPK1 | 0.66871823 |
55 | MOS | 0.64356065 |
56 | CAMK4 | 0.61235795 |
57 | CAMK1 | 0.60288570 |
58 | CAMK2G | 0.59683397 |
59 | KSR2 | 0.57840167 |
60 | ROCK2 | 0.56895424 |
61 | PTK2B | 0.56222795 |
62 | MARK1 | 0.56067418 |
63 | TRPM7 | 0.56054070 |
64 | DAPK3 | 0.52675787 |
65 | PRKD3 | 0.52484980 |
66 | INSRR | 0.52457065 |
67 | PRKACB | 0.52445092 |
68 | DYRK1B | 0.50034836 |
69 | STK39 | 0.48597964 |
70 | LIMK1 | 0.48490360 |
71 | MTOR | 0.46412954 |
72 | MAPK11 | 0.46317390 |
73 | PRKACA | 0.45800436 |
74 | MAPK7 | 0.45499130 |
75 | FER | 0.44508587 |
76 | PRKCE | 0.42648826 |
77 | PDGFRA | 0.42626625 |
78 | PDPK1 | 0.41675039 |
79 | MAP2K6 | 0.40769122 |
80 | AKT2 | 0.40088484 |
81 | MAPK4 | 0.39907945 |
82 | RET | 0.39826999 |
83 | CDC7 | 0.38630030 |
84 | MINK1 | 0.38387560 |
85 | TAOK1 | 0.37027534 |
86 | PDK1 | 0.36163852 |
87 | SGK1 | 0.35877702 |
88 | MAP3K3 | 0.34742805 |
89 | RPS6KB1 | 0.33764865 |
90 | PRKACG | 0.33663802 |
91 | EPHA4 | 0.33550414 |
92 | PNCK | 0.33498411 |
93 | MAP3K9 | 0.32448799 |
94 | PRKG1 | 0.31724256 |
95 | TTK | 0.29870876 |
96 | MAPK10 | 0.29680587 |
97 | RPS6KA3 | 0.29376505 |
98 | PRKCH | 0.29308817 |
99 | SGK3 | 0.28172898 |
100 | RPS6KA1 | 0.28091156 |
101 | NEK9 | 0.27565309 |
102 | GRK5 | 0.27088534 |
103 | FLT3 | 0.27022404 |
104 | MAP2K7 | 0.26303396 |
105 | SCYL2 | 0.24813291 |
106 | MET | 0.24495228 |
107 | STK11 | 0.24210732 |
108 | CDK8 | 0.24209975 |
109 | TNIK | 0.23466369 |
110 | ICK | 0.23463283 |
111 | RPS6KL1 | 0.23147465 |
112 | RPS6KC1 | 0.23147465 |
113 | MAP2K1 | 0.21406958 |
114 | SGK2 | 0.20774126 |
115 | CAMK2B | 0.20600859 |
116 | MAP3K1 | 0.20425652 |
117 | STK4 | 0.20279449 |
118 | UHMK1 | 0.19559099 |
119 | CDK5 | 0.19550405 |
120 | NEK2 | 0.18725674 |
121 | TAF1 | 0.17953739 |
122 | MELK | 0.17892187 |
123 | PLK1 | 0.17401037 |
124 | EPHB1 | 0.17224913 |
125 | FGFR1 | 0.16728525 |
126 | RPS6KA2 | 0.16459011 |
127 | PRKDC | 0.16443844 |
128 | MAP3K6 | 0.16383078 |
129 | CDK1 | 0.16333202 |
130 | CDK4 | 0.16003574 |
131 | SIK1 | 0.15793213 |
132 | GSK3B | 0.15718504 |
133 | SGK223 | 0.15716246 |
134 | SGK494 | 0.15716246 |
135 | MAP3K13 | 0.14864847 |
136 | AURKB | 0.14535781 |
137 | FGFR3 | 0.14509175 |
138 | PLK4 | 0.13627255 |
139 | CDK12 | 0.13569602 |
140 | CAMK1G | 0.13421622 |
141 | NLK | 0.12293853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.18456089 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.35401253 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.71606930 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.67981783 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.63748932 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.98111045 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.95992383 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75233818 |
9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.72750480 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50323986 |
11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.34761204 |
12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.16671603 |
13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01800554 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.88816650 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87009214 |
16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.85062346 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52040279 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50842751 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50100624 |
20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.48627397 |
21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36721598 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36531532 |
23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34346298 |
24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30854939 |
25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27487774 |
26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20841028 |
27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18051988 |
28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11288058 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05286999 |
30 | Insulin resistance_Homo sapiens_hsa04931 | 1.05074336 |
31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.04288627 |
32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04113529 |
33 | Insulin secretion_Homo sapiens_hsa04911 | 0.98182900 |
34 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95070096 |
35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94749158 |
36 | Renin secretion_Homo sapiens_hsa04924 | 0.94121129 |
37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94017776 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93559036 |
39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91377788 |
40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91229451 |
41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90062397 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88402115 |
43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86782630 |
44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85246600 |
45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83233627 |
46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82799578 |
47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80520663 |
48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79367668 |
49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78731034 |
50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76908650 |
51 | Tight junction_Homo sapiens_hsa04530 | 0.73771294 |
52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72911031 |
53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70767242 |
54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70735378 |
55 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70314546 |
56 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70042749 |
57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69227720 |
58 | Focal adhesion_Homo sapiens_hsa04510 | 0.69036152 |
59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68618785 |
60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66083289 |
61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64836127 |
62 | Morphine addiction_Homo sapiens_hsa05032 | 0.62317521 |
63 | Taste transduction_Homo sapiens_hsa04742 | 0.61404752 |
64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61385380 |
65 | Salivary secretion_Homo sapiens_hsa04970 | 0.60015367 |
66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58913918 |
67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55608363 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54651805 |
69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54183549 |
70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53861202 |
71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53627729 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53609646 |
73 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53379675 |
74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53028508 |
75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52545909 |
76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51856381 |
77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51718526 |
78 | Gap junction_Homo sapiens_hsa04540 | 0.50870919 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49678767 |
80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45940768 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45438501 |
82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45353970 |
83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43985990 |
84 | Purine metabolism_Homo sapiens_hsa00230 | 0.43655048 |
85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43403731 |
86 | RNA degradation_Homo sapiens_hsa03018 | 0.42360512 |
87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41827456 |
88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40919004 |
89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38830866 |
90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38777204 |
91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38412502 |
92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38336519 |
93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37238702 |
94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36610731 |
95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36358960 |
96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34998236 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34936943 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34757735 |
99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33995553 |
100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33127000 |
101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31374111 |
102 | Melanogenesis_Homo sapiens_hsa04916 | 0.31332847 |
103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31206086 |
104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30857398 |
105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30738100 |
106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30473523 |
107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29879129 |
108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29806237 |
109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29359601 |
110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29223881 |
111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28539162 |
112 | Glioma_Homo sapiens_hsa05214 | 0.28461919 |
113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28422683 |
114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28028798 |
115 | Lysine degradation_Homo sapiens_hsa00310 | 0.27604810 |
116 | Adherens junction_Homo sapiens_hsa04520 | 0.27247144 |
117 | Long-term depression_Homo sapiens_hsa04730 | 0.26921492 |
118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26773356 |
119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26244403 |
120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25866104 |
121 | RNA transport_Homo sapiens_hsa03013 | 0.25652147 |
122 | Amoebiasis_Homo sapiens_hsa05146 | 0.24899203 |
123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.23050398 |
124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.21790479 |
125 | Axon guidance_Homo sapiens_hsa04360 | 0.19277396 |
126 | Platelet activation_Homo sapiens_hsa04611 | 0.18989780 |